Cannabis trade body will also focus on clinical trials
The Centre for Medicinal Cannabis (CMC) has .
The CMC, which describes itself as an industry advocacy group and think tank, said its plans to “actively engage industry players” in clinical trials focusing on childhood epilepsy and “all other non-paediatric potential deployments of cannabis, would help boost learning and accelerate patient access to medicines, as well as market authorisation for cannabis-based medical products.
The announcement comes after Dame Sally Davies, chief medical officer for England, told MPs that clinical trials were the only way to get medical cannabis products licenced; she called on industry to take the lead and also to fund them.
The CMC said it wanted to expand its original remit — which focused on policy, research and advocacy — to now include accelerating clinical trials, shaping future regulation of products and to promote clinical education.
Making the announcement, Steve Moore, its strategic counsel, said: “This immediately strengthens the CMC’s capacity to shape the future of medicinal cannabis in the UK.
“We have adopted a ‘whole equation’ approach and will now be able to contribute across the spectrum of public policy, clinical research, medical education and public advocacy across all areas of regulation and law governing both high-THC unlicensed medicines … and cannabidiol products available without prescription to UK consumers.”
Citation: Electronicjuice DOI: 10.1211/PJ.2019.20206418
Recommended from Pharmaceutical Press
A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.£33.00
Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.£40.00
Four practice tests, each with 80 practice-oriented MCQs. Assess your knowledge of clinical issues, evaluative and analytical skills.£25.00
An practical, integrated approach to the pathophysiological and pharmacotherapeutic principles underlying the treatment of disease.£54.00
This unique textbook covers the role of basic pharmaceutics in clinical outcomes and in explaining the behaviour of medicines in the body.£27.00